Position in HROW
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$16,459,036
+$3,477,115 QoQ
Shares Held
387,545
+5.3% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#12
of 221 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RICE HALL JAMES & ASSOCIATES, LLC holds $193,433,636 across 12 Drug Manufacturers - Specialty & Generic names. HROW ranks #7 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
624,928 | $39,964,145 | |
| 2 | PBH |
Prestige Consumer Healthcare Inc.
|
689,692 | $32,601,740 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
2,332,043 | $23,320,430 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
490,221 | $22,800,178 | |
| 5 | ALKS |
Alkermes plc.
|
390,866 | $20,481,378 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
100,195 | $16,886,865 | |
| 7 | HROW |
Harrow, Inc.
This page
|
387,545 | $16,459,036 | |
| 8 | EOLS |
Evolus, Inc.
|
1,289,888 | $8,951,822 |
All Filings in HROW
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,459,036 | 387,545 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $12,981,921 | 368,177 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,737,902 | 361,998 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,077,425 | 333,695 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $11,318,948 | 370,627 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $7,878,175 | 296,172 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $10,417,644 | 310,511 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $14,157,049 | 314,881 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $5,344,957 | 255,862 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $3,242,686 | 245,101 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $2,592,396 | 231,464 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,597,960 | 250,380 | Shares | Sole | 2023-11-02 | |
| No filing history on record for this holder in this stock. | ||||||